Cetuximab, Docetaxel, Crb-701, Capcitabine
Oropharyngeal Carcinoma (Opc)
Phase III
Not Yet Recruiting
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
Aug 12, 2026
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Corbus Pharmaceuticals (3371) have in its pipeline
3371 is currently developing the following drugs: Cetuximab, Docetaxel, Crb-701, Capcitabine, Crb-913, Crb-601 Monoclonal Antibody, Anti-Pd-1 Monoclonal Antibody. These drug candidates are in various stages of clinical development as the company works toward FDA approval.